The TRT market has clearly stabilized - and Axiron appears to be making a gradual uptick... will hold off calling this a return to growth until another couple of quarter results.
They are starting to focus on expanding the pipeline - the messaging is better and more positive... the idea that this is a fully funded biotech is a good one and they do have some interesting IP / areas of focus here.... Now its time to deliver on these!!!
Ann: 2015 AGM Presentation and Script, page-2
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.28M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 46219 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 185000 | 2 |
View Market Depth
| Last trade - 10.00am 10/09/2024 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable